Clinical observation on effect of Kanglaite ( ) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy

Xianfu Wang; Changjin Ma; Wang Xiuqing

doi:10.1007/BF02934653

Your Location：

Home >

Browse articles >

Clinical observation on effect of Kanglaite ( ) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy

OriginalPaper | Updated：2021-08-27

- Clinical observation on effect of Kanglaite ( ) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy
- Clinical observation on effect of Kanglaite ( ) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy
- 中国结合医学杂志（英文版） 1999年5卷第2期页码：105-107
- Affiliations：
  
  1. The Third Clinical College of Norman Bethune Medical University,Changchun
  2. The Central Institute of Oncology, Sun Yetsen University of Medical Sciences,Changchun
- Author bio：
- Funds：
- DOI：10.1007/BF02934653
  中图分类号：
- 纸质出版日期：1999，
Scan for full text
Wang, X., Ma, C. & Wang, X. Clinical observation on effect of Kanglaite () in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy., CJIM 5, 105–107 (1999). https://doi.org/10.1007/BF02934653

Xianfu Wang, Changjin Ma, Wang Xiuqing. Clinical observation on effect of Kanglaite ( ) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy[J]. Chinese Journal of Integrative Medicine, 1999,5(2):105-107.
Wang, X., Ma, C. & Wang, X. Clinical observation on effect of Kanglaite () in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy., CJIM 5, 105–107 (1999). https://doi.org/10.1007/BF02934653 DOI：

Xianfu Wang, Changjin Ma, Wang Xiuqing. Clinical observation on effect of Kanglaite ( ) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy[J]. Chinese Journal of Integrative Medicine, 1999,5(2):105-107. DOI： 10.1007/BF02934653.

摘要

Objective: To study the effect of Kanglaite (KLT) in treating pulmonary carcinoma (PC) patients with Lung-Qi Deficiency and immunologic inadequacy (LDII) after pneumonectomy.Methods: Thirtysix patients of PC-LDII were treated with KLT and the lymphocyte subset was examined before and after treatment.Results: The markedly effective rate of treatment was 50.0% and the total effective rate 66.7%. Immunological examination showed that the lymphocyte subset of patients tended to get normal and the difference between pre-treatment and post-treatment was significant.Conclusion: KLT could improve the symptom of Lung-Qi Deficiency and markedly strengthen the immune function of PC patients.

Abstract

关键词

Kanglaitepulmonary carcinomaLung-Qi Deficiencyimmune function

Keywords

Kanglaitepulmonary carcinomaLung-Qi Deficiencyimmune function

references

1986, 6(10): 598.

1 1995: 19–21, 499–500.

1 1993: 1–2, 91–94.

1 1984: 99–105.

1 1980: 204–205.

1 1980: 146–147.

FULL TEXT LINK

More>

浏览量

343

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Fuzheng Yiliu Granule (扶正抑瘤颗粒) inhibits the growth of hepatocellular cancer by regulating immune function and inducing apoptosis in vivo and in vitro

Clinical observation on the endocrinal and immune functions in subjects with yin-deficiency constitution

Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 (当归补血汤1号) in treating patients of non-small cell lung cancer at peri-operational stage

Effect of TCM combined with chemotherapy on immune function and quality of life of patients with non-small cell lung cancer in stage III-IV

Effect of fuzheng kangbai granule on immune function and survival time in minimal residual leukemia model mice